首页 | 本学科首页   官方微博 | 高级检索  
     

血清miRNA表达水平检测与原发性肝癌早期诊断的研究
引用本文:刘建华,程涛,王洪敏,王海. 血清miRNA表达水平检测与原发性肝癌早期诊断的研究[J]. 广东寄生虫学会年报, 2010, 0(6): 666-668,706
作者姓名:刘建华  程涛  王洪敏  王海
作者单位:[1]山西省太原市传染病医院,太原030012 [2]解放军四五八医院全军肝病中心,广州510060 [3]中山大学达安基因股份有限公司,广州510080
摘    要:目的对血清样品miRNA表达水平变化的实时定量PCR检测进行观察,同组织样品的miRNA的变化趋势进行比较,以评价血清miRNA在原发性肝癌早期诊断中的价值。方法通过荧光定量PCR检测miRNA-125a、-200a、-199a等3个有代表性的miRNA指标在正常和癌变样品中的变化,验证组织及血清两类样品中miRNA的变化趋势,分别取癌旁组织和癌组织以及正常人与癌症患者血清为材料。结果肝癌患者血清是正常对照血清中miRNA的含量的10%~15%,肝癌组织中的miRNA含量是癌旁组织的10%~20%,而且血清miRNA的变化趋势与组织miRNA较一致。结论血清miRNA可以反映原发性肝癌的发生,说明血清miRNA非常有可能成为一种新的生物标记物用于原发性肝癌的早期诊断。

关 键 词:原发性肝癌  miRNA  血清  早期诊断

Serum miRNA in the Early Diagnosis of Primary Hepatic Carcinoma
LIU Jian-hua,CHENG Tao,WANG Hong-min,WANG Hai. Serum miRNA in the Early Diagnosis of Primary Hepatic Carcinoma[J]. Journal of Tropical Medicine, 2010, 0(6): 666-668,706
Authors:LIU Jian-hua  CHENG Tao  WANG Hong-min  WANG Hai
Affiliation:1.Taiyuan Infection Disease Hospital in Shanxi Provine,Taiyuan 030012;2.The Centre for Army Liver Disease of Liberation Army Four Five Eight Hospital,Guangzhou 510060;3.Daan Gene Co.,Ltd.of Sun Yat-sen University,Guangzhou 510080,China)
Abstract:Objective The evaluate the use of miRNA as biomarker for the early diagnosis of primary hepatic carcinoma(PHC).Methods Three representative miRNAs(miRNA-125a,-200a and-199a) were selected in this study.Their expression in serum and tissues was monitored by real-time PCR.Results The expression levels of all the three miRNA in serum from PHC patients were about 10%~15% of the normal serum.Similarly,their expression level in PHC tissues was also 10%~20% lower than their adjacent tissues.Conclusion The level of serum miRNA125a,-200a and-199a can be used as biomarkers for the early diagnosis of PHC.
Keywords:primary hepatic carcinoma  miRNA  serum  early diagnostic test
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号